New Method to Detect RNA Viruses More Effective and Faster than PCR Test
A new innovative method to detect RNA viruses based on the triplex-forming probe technology paves the way for new options for detecting viruses such as SARS-CoV-2, the influenza A virus (H1N1) or the respiratory syncytial virus (RSV), a pathogen that affects newborn babies and needs careful differential diagnosis. More...01 Mar 2023
World’s First AI-Powered Diagnostic Test Accurately Identifies Respiratory Viruses in Five Minutes
A world-first diagnostic test powered by AI that can identify known respiratory viruses within five minutes from just one nasal or throat swab could replace current testing methods which are limited to testing for just one infection or are either lab-based and time-consuming or fast and less accurate. More...09 Feb 2023
POC Test Detects and Differentiates Between Upper Respiratory Infections Caused by Influenza and SARS-CoV-2
A fast, polymerase chain reaction (PCR) device can detect and differentiate between upper respiratory infections caused by Influenza (Flu) A & B, and SARS-CoV-2 (COVID-19). More...04 Jan 2023
New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
Researchers have developed a new immunosensor based on Quenchbody technology that shows great potential as a fast, inexpensive, and convenient tool to detect SARS-CoV-2. This highly efficient diagnostic approach will be useful not only for point-of-care testing, but also for high-throughput epidemiological studies of COVID-19 and other emerging infectious diseases. More...19 Dec 2022
Long COVID Etiologies Found in Acute Infection Blood Samples
Long COVID or long-haul COVID (also known as post-acute sequelae of COVID-19 [PASC], or chronic COVID syndrome [CCS]) is a condition characterized by long-term health problems persisting or appearing after the typical recovery period of COVID-19. More...12 Dec 2022
Cepheid's Multi-Target Test Design Enables Detection of Influenza Variants
Cepheid’s (Sunnyvale, CA, USA) respiratory test design enables detection of the currently circulating mutant strains of influenza, and with similar symptoms across various illnesses such as the flu, respiratory syncytial virus (RSV) disease, and COVID-19, when accurate and fast diagnosis is critical to patient care. More...09 Dec 2022
Novel Device Detects COVID-19 Antibodies in Five Minutes
Rapid, cheap and accurate tests continue to be essential for epidemiological surveillance and for health services to monitor and contain the spread of SARS-CoV-2. A team of scientists has now developed an electrochemical immunosensor that detects antibodies against the virus. More...30 Nov 2022
In Other News
CRISPR-Powered COVID-19 Test Detects SARS-CoV-2 in 30 Minutes Using Gene Scissors
Gut Microbiome Dysbiosis Linked to COVID-19
Novel SARS CoV-2 Rapid Antigen Test Validated for Diagnostic Accuracy
New COVID + Flu + R.S.V. Test to Help Prepare for `Tripledemic`
AI Takes Guesswork Out Of Lateral Flow Testing
Rapid Antigen Tests Detect Omicron, Delta SARS-CoV-2 Variants
Fastest Ever SARS-CoV-2 Antigen Test Designed for Non-Invasive COVID-19 Testing in Any Setting
Blood Test Performed During Initial Infection Predicts Long COVID Risk
Health Care Professionals Showed Increased Interest in POC Technologies During Pandemic, Finds Study
Set Up Reserve Lab Capacity Now for Faster Response to Next Pandemic, Say Researchers
One-Time Blood Test Predicts Which Hospitalized COVID-19 Patients Will Grow Worse
Low-Cost COVID-19 Testing Platform Combines Sensitivity of PCR and Speed of Antigen Tests
Finger-Prick Blood Test Identifies Immunity to COVID-19
IL-1RA Antibodies in Myocarditis After SARS-CoV-2 Vaccination
Quick Test Kit Determines Immunity Against COVID-19 and Its Variants
New Breakthrough Test Detects and Predicts COVID-19 Severity
Siemens Launches New Combination Tests for SARS-CoV-2 and Seasonal Respiratory Pathogens
Guanidine-Free Molecular Transport Medium Improves COVID-19 Testing Safety
Finger Prick Test Could Predict COVID-19 Complications from Drop of Blood
Low Testosterone Levels Tied to More Severe COVID in Men
Several Biomarkers Predict Progression of SARS-CoV-2 Infection
First Diagnostic Test for Long COVID Provides More Than 90% Accuracy